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Pyruvate Kinase Isoform M2 Influences Autophagy and 
Related Processes in Hepatocellular Carcinoma Cells 
 
Matthew Lin1, Department of Physiology & Neurobiology, University of Connecticut, Storrs, 
Connecticut 06269 
 
Abstract: Hepatocellular carcinoma (HCC) is the most common form of liver cancer that affects 
~14 million people in the world. Like all cancers, HCC is a disease that arises from unstinted 
cellular growth initiated by genetic alterations, metabolic changes, and dysregulation in key 
cellular pathways. Of interest is the relationship between metabolism and cell 
proliferation/degradation for therapeutic targeting. Pyruvate kinase M2 is a dimeric, 
glycolytically inactive isoform of the final enzyme involved in glycolysis, that is often 
upregulated in cancerous tissue. It is thought that the enzymatic function of PKM2 outside of 
glycolysis contributes to the biosynthesis of anabolic intermediates used in cell growth and 
division. Autophagy is a recycling process by which cells selectively degrade defective 
components and is implicated in cell death pathways. Because PKM2 is upregulated in HCC 
and links metabolism and tumorigenesis, we investigate its role in regulating autophagy and 
associated processes. In this study, shRNA constructs were used to knockdown and 
overexpress the PKM2 isoform in vitro to observe its effect on autophagy and related 
processes, thus establishing a working model for how autophagy is regulated in HCC cells and 
potential therapeutic targeting. 
 
Hepatocellular Carcinoma 
 
Hepatocellular carcinoma (HCC) represents 65% of liver cancer cases in the United 
States.1 Across the world, HCC is the third most common cause of cancer-related deaths and 
the number of HCC cases is expected to rise to 22 million in the next twenty years.2 
Populations where hepatitis B virus is endemic have more prevalence of HCC: China, 
Mongolia, Southeast Asia, and Sub-Saharan Western and Eastern Africa have a predominance 
of HCC cases.1 Other causative factors include alcohol consumption and associated cirrhosis, 
hepatitis C/D virus, and non-alcoholic fatty liver disease.1 Such assaults to the liver—namely 
to hepatocytes, which comprise a majority of the tissue and carry out important metabolic, 
biosynthetic, storage, and detoxification functions—predispose it to metabolic dysregulation 
and oxidative injury, which leads to cycles of inflammation, cell death, repeated compensatory 
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regeneration, and accumulation of genetic mutations.3 HCC, then, can be understood as a 
disease rooted in genomic alterations, metabolic changes, and regulatory dysfunction. 
Currently, the Wang Lab in the Physiology and Neurobiology department at the 
University of Connecticut has constructed a broad picture of hepatocellular carcinoma. It was 
previously shown that the nuclear receptor small heterodimer partner (SHP) functioned to 
suppress hepatic tumorigenesis as a pleiotropic regulator: modulating metabolic pathways, 
the stress and inflammatory responses, detoxification, cellular adhesion and differentiation, 
cell cycle control, and apoptosis.4 In addition, High-Mobility-Group Protein 2 was shown to be 
highly induced in liver tumor initiating cells, and abrogating its function led to a decrease in 
the pluripotency of tumor-initiating cells.5 Interestingly, metabolic regulator pyruvate 
dehydrogenase kinase-4 (PDK4) has been implicated in the apoptosis pathway, as seen by 
massive cell death events in mice with PDK4 knocked-out who were exposed to the 
carcinogenic agent diethylnitrosamine (DEN).(unpublished) These findings illuminate the tortuous 
molecular landscape of HCC, and provide insight into the links between metabolism, 
tumorigenesis, and cell death. 
Pyruvate Kinase 
 
Pyruvate kinase (PK) is the rate-limiting enzyme in the last step of glycolysis. By 
removing the phosphate group from phosphoenolpyruvate and transferring it to an ADP 
molecule, PK catalyzes the formation of a pyruvate and an ATP molecule. There are four 
isoforms of pyruvate kinase in humans, and each one is associated with a different tissue 
type. PKL is expressed primarily in the liver; PKR is found in red blood cells; PK isoform M1 
(PKM1) is localized in most adult tissues with high ATP requirements; and PK isoform M2 
(PKM2) is a splice variant of PKM1, whereby exon 10 is included in place of exon 9, and it is 
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associated with embryonic tissue.6 Interestingly, PKM1 in its canonical form exists as a 
tetramer and is metabolically and glycolytically highly active; however, PKM2 is primarily found 
in a dimeric form that is less glycolytically active, but is preferentially upregulated in cancerous 
tissue. It is thought that expression and activity of dimeric PKM2 endows cancer cells with the 
aerobic glycolysis activity characteristic of the Warburg effect.7,8 In fact, it has been shown 
that the dimeric form of PKM2 might have enzymatic function outside of the metabolic 
pathway such as shunting resources to biosynthesis, phosphorylating downstream proteins 
like SNAP-23 for exosome formation and secretion into the tumor microenvironment, 
contributing to chromosome segregation, interacting with proteins that form contractile rings 
for cytokinesis, and activating chaperone-mediated autophagy.9,10,11 A study by He et al. 
examined renal cell carcinoma and breast cancer to illustrate the phosphorylative ability of 
PKM2 and its role in inhibiting autophagy through AKT1S1 S202/203 phosphorylation, which 
activates mTORC1 and abrogates ATG1 complex formation.12 Furthermore, studies have 
shown that knocking-down PKM2 in lung carcinoma cells increased autophagosome 
formation, while overexpressing PKM2 accelerated oncogenic proliferation and inhibited 
autophagy in cancer cells.13,14 Because PKM2 is involved in the glycolysis pathway upstream 
of PDK4—which we have previously identified as a regulatory agent of apoptosis in carcinogen-
challenged mice—and because its role in tumor progression, anabolic potentiation, and cell 
death is clearly associated, it represents an interesting target of autophagy and study in the 
context of HCC. 
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Figure 1. (A) Tumor cells preferentially express dimeric PKM2 that funnels glycolytic intermediates into 
biosynthetic pathways.15 (B) Tetrameric PKM2 pushes glucose intermediates towards pyruvate formation, 
while low PKM2 leads to biosynthesis.9 
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Autophagy 
 
 Autophagy is a cellular recycling process by which cells degrade intracellular 
components, including targets that are too large for other degradative systems, in response 
to external and internal stressors. In essence, autophagy functions as a third arm of cellular 
clearance, with the other two being apoptosis and necroptosis. There are three categories of 
autophagy: macroautophagy, microautophagy, and chaperone-mediated autophagy.16 
Macroautophagy is the best characterized form of autophagy in cells. Briefly, the molecular 
mechanisms of autophagy require a stress stimulus that causes formation of double-
membrane vesicles, which engulf cytoplasmic contents and fuse with lysosomes that degrade 
captured substances. Important proteins that mediate this process are LC3, which is the 
commonly used name for microtubule-associated protein 1 light chain 3 and is a ubiquitin-
like molecule; Beclin-1, which connects the apoptosis and autophagy pathways through its 
binding to apoptosis inhibitor Bcl-2, and also helps localize autophagic proteins to pre-
autophagosomal structures; and Vps34, which is a vesicular protein sorting enzyme that binds 
Beclin-1 and acts as a PI3-kinase that is essential to phagophore elongation.17,18,19 In cancers, 
autophagy-associated cell death and autophagy more generally is purported to act as a tumor 
suppressor, and loss or inhibition of autophagy is correlated with genomic instability, necrosis, 
and apoptosis.13,20,21 Nevertheless, autophagy appears to be context-dependent as it can also 
help increase tumor survival, thought to provide metabolites from degradation as substrates 
for anabolic reactions.22 Reviews of anticancer compounds have confirmed this dual-nature 
of autophagy, with certain compounds such as aminoquinolines working via inhibition of 
autophagy purportedly repressing cancer activation, and other drugs inducing autophagy to 
prevent tumor progression.23 It has been observed, however, that overwhelming activation of 
autophagy and the accumulation of autophagolysosomes leads to autophagy-associated cell 
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death.24 There is controversy in the field whether this event is causal or incidental to cell 
death.24 While debated, it is of interest to understand the regulation of autophagy in cancer 
cells because therapeutics that induce autophagy synergize with autophagy inhibitors for 
anticancer effects both in many cancer cell lines and in xenograft models. 
 Moreover, the link between PKM2 and autophagy has been established. PKM2 is often 
acetylated in high glucose concentrations, which decreases its activity and promotes its 
lysosomal-dependent degradation via chaperone-mediated autophagy.9 The presence of 
acetylated PKM2 conferred tumor growth advantage both in vitro and in vivo for lung 
carcinoma tissue.7 In addition, the knockdown of PKM2 in lung carcinoma cells led to induced 
apoptosis and autophagy; upon inhibition of autophagy with chemical inhibitor 3-
methyladenine (3-MA), apoptosis was observed in higher frequency.13 P300/CBP-associated 
factor (PCAF) overexpression was shown to promote cell autophagy and elicit cell death in 
Huh7 and Hep3b HCC cell lines.21 In the Wang lab, RNA-seq analysis of hepatocellular 
carcinoma mouse samples probed for upregulation of certain genes and was able to isolate 
a panel of cell-cycle and glycolytic enzymes that exhibited differential expression (Figure 2). 
However, many human samples have been confirmed to show an increased expression of 
PKM2.25 Thus, the proposed experiment will modulate the expression levels of PKM2 to 
observe its effect on autophagy and associated cell death or other processes among HCC cell 
lines.  
 
 
 
 
 
Figure 2. RNAseq heat map of select genes 
up- and down-regulated in DEN-induced mice 
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Methods & Materials 
 
Cell Culture 
Human embryonic kidney cell line HEK293T, and human hepatocellular carcinoma cell lines 
Huh7 and Hep3B cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM, 
25 mM glucose; Life Technologies). All mediums were supplemented with 10% fetal bovine 
serum and 1% antibiotics (100 U/mL penicillin and 100 U/mL streptomycin). Cells were 
maintained at 37ºC in a humidified cell incubator at 20% O2, 5% CO2 in air (normoxia 
conditions).  
 
shRNA plasmid isolation 
Two short-hairpin RNA constructs were used to target PKM2 messenger RNA. Two bacterial 
stocks of MISSION shRNA were purchased from Sigma Aldrich as glycerol stock: 
TRCN0000291062 
(#2: 5’-CGGCTTTCCTGTGTGTACTCTGTCCTCGAGGACAGAGTACACACAGGAAAGTTTTTTG-3’), which 
targets the terminal end of coding sequence from amino acid 325 to 345, and 
TRCN0000296768  
(#8: 5’-CCGGGTTCGGAGGTTTGATGAAATCCTCGAGGATTTCATCAAACCTCCGAACTTTTTTG-3’), which 
targets at the 3’UTR. Bacteria were streaked on ampicillin-positive LB-agar plates and 
incubated overnight at 37º. 18 hours following inoculation, several colonies were selected 
and transferred to tubes of ampicillin-positive LB media and shaken overnight at 37º. 
Following an additional 18 hours, these solutions were collected and mini-prep plasmid 
purification (Qiagen) was carried out. Plasmid was quantified by NanoDrop spectrophotometry 
analysis and placed into sterile tubes for storage. 
 
Lentiviral Infection 
Purified plasmid was transfected into HEK293T cells using lipofectamine reagent 
polyethylenimine (PEI). Briefly, purified shRNA, pMD.2G (VSVG envelope) and pPAX (group-
antigen gene “gag” and polymerase) were mixed together with 1:2 wt/vol PEI and 1:100 
wt/vol and Dulbecco’s Modified Eagle’s Medium (DMEM) and incubated at room temperature 
for 30 minutes.26 Target cells (Huh7/Hep3B) were seeded 24 hours prior to transfection to 
allow for surface adhesion but optimized exposed surface area for liposome contact. 
Packaged lipofectamine solution was then added dropwise to each well and shaken to evenly 
apply across the monolayer. Media was changed 6 hours later to wash out remaining PEI, 
which is toxic to cells. Viral titers were collected using a 0.45 nanopore filter and syringe every 
24 hours for 3 days. Fresh media was added after collection each day. Collected viral media 
was added dropwise to target cells (Huh7/Hep3B) each day for 3 days. Transduced cells were 
allowed to grow and selected using puromycin. Knocked-down expression was monitored with 
western blot analysis. See Figure 9A for a schematic of this technique. 
 
Viral Ultracentrifugation 
Collected viral media was pooled into a sterile 50-mL Falcon tube and stored at 4ºC over three 
days of collection. At the end of collection, samples were transferred to autoclaved 
polypropylene tubes and balanced with DMEM media. Equal volume and mass samples were 
then centrifuged for 2 hours at 25,000 rpm at 4º. Supernatant was poured off and viral pellets 
were reconstituted in 500µL of complete media. Typically, titers would be measured of these 
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samples; however, due to time constraints and low volumes, all viral solutions were used to 
treat the target cells for experimentation. 
 
Transient Plasmid Transfection 
DNA/shRNA constructs were packed into lipofectamine nanoparticles as described 
previously. Packaged particles were applied dropwise to cells 24 hours after they had been 
seeded. Media was changed 6 hours post-transfection and cells were selected using 
puromycin. Experiments were conducted in the 3 days following transient transfection to 
ensure that expression of plasmid was maximized.  
 
Autophagy starvation experiment 
Autophagy can be induced chemically (rapamycin) and metabolically (through starvation).27,28 
One control and two knockdown cell lines were subjected to three media conditions. Control 
groups were incubated in complete media 24 hours; group 2 were incubated in DMEM for 48 
hours; group 3 were incubated in DMEM for 72 hours. Each of these three groups were used 
for each treatment group (control, knockdown, overexpression, etc.). Cells were collected for 
Western Blot Analysis at each time point by washing them with phosphate buffered saline 
(PBS), scraping with a cell scraper, and transferring to a sterile tube. Cells were centrifuged at 
15,000xg for 30 seconds and supernatant was aspirated. Cells were reconstituted in lysis 
buffer and incubated on ice for 10 min. Lysis solution was centrifuged for 15 minutes at 
12,000xg at 4ºC. Supernatant was transferred to a sterile tube and quantified using BCA.  
 
Overexpression + Inhibition/Induction of Autophagy  
E. coli transformed with PKM2-GFP was grown on kanamycin-positive LB-agar plates. Colonies 
were isolated and inoculated into kanamycin-positive LB media and shaken overnight, as 
previously described. Plasmid were purified via Qiagen mini-prep and quantified via nanodrop 
absorbance spectroscopy. Plasmid was transfected transiently into Huh7 and Hep3B cells 
and selected via fluorescence activated cell sorting (FACS) for growth. Overexpressed PKM2 
cells were subjected to starvation experiment conditions and monitored for PARP cleavage 
and p70S6 kinase cleavage, both markers for apoptosis.29 In addition, MTS cell viability 
assays and TUNEL staining or Annexin V/PI flow cytometry were conducted for functional 
analysis. 
 
For inhibition of autophagy, cells that were virally transduced were selected using FACS sorting 
and allowed to grow. Autophagy inhibitor (3-methyladenine/anti-ATG/chloroquine) was given 
in increasing doses and WBA was analyzed to observe effect on starved cells at different time 
points.30 Markers of autophagy and apoptosis were monitored using WBA.  
 
For induction of autophagy, cells that were virally transduced to knockdown expression of 
PKM2 were co-cultured with rapamycin, a potent autophagy inducer. Similar analytical 
methods were conducted as for the overexpressed/inhibited cells. 
 
Western Blot Analysis & Quantification 
Protein lysates were collected and quantified via bicinchoninic acid assay (Pierce BCA Assay), 
using bovine serum albumin standards as reference controls. Once total protein 
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concentrations were quantified in samples, equal quantities of protein sample were loaded 
into 8-15% agarose gels and run at 80-100mV for 90-120 minutes. Bands were transferred 
to nitrocellulose membranes by applying a 100 mV electrical field across the gel and between 
sponges in transfer buffer (Tris + glycine, H2O, MeOH) for 2 hours at 4ºC. Post-transfer 
membrane was then blocked with 5% milk for 30 min. to 2 hours. Blots were then probed with 
anti-PKM2, anti-LC3b, and anti-actin before applying secondary anti-rabbit antibody linked to 
HRP. Bands were visualized via enhanced chemiluminescence (ECL). Quantification of bands 
was conducted using the ImageJ imaging program. 
 
Results 
 
Knockdown of PKM2 isoform in Huh7 cells led to an increase in autophagosome formation. 
 
The relationship between pyruvate kinase M2 expression levels and autophagy levels 
were analyzed in vitro. The Huh7 cell line (originally isolated from a 57-year-old Japanese 
patient with well-differentiated HCC) was chosen for its demonstrated ability to be readily 
transfected and manipulated.31,32 To conduct knockdown experiments, two short-hairpin RNA 
(shRNA) constructs that were validated as 99% efficient were purchased from Sigma-Aldrich. 
Upon first pass viral packaging and transduction, the packaging cell line appeared to die in 
large quantities (not shown); nevertheless, the target cells thus seemed to exhibit noticeable 
decrease in protein levels of PKM2 in both knockdown conditions, though efficiency was not 
very high (Figure 3). All expression levels were normalized to the short hairpin non-targeting 
(shNT) control, with sh#2 showing about half expression at 0.51 and sh#8 knocking down 
expression to 0.40 of the control level’s (Figure 3). A second set of viral packaged cells were 
established after the first set died from cell damage. It was noted that 293T cells are 
particularly susceptible to mechanical agitation and often lifted off of the bottom of the cell 
culture dish upon the slight perturbation. To improve the technique of viral transfection, all 
solutions were added in a dropwise-fashion across the surface, rather than down the sides of 
the dishes. The second-line of cells that were established were much healthier. 
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Once this second line of healthy, knocked-down cells was confluent, it was seeded for 
the starvation experiment. Western blot analysis was used to visualize the knockdown effect 
in the cells, as well as a measure of autophagy levels. The knockdown effect was observed to 
increase as starvation period increased (Figure 4). Autophagy levels were observed through 
anti-LC3B probing. Due to a low efficiency knockdown, the levels were not significantly 
different across treatment groups (not shown). A third round of experimentation was 
conducted to improve knockdown efficiency in these cells. 
After several more attempts at viral transfection, an efficiently knocked down line of 
Huh7 cells was established (Figure 5A). Knockdown efficiency was quantified and normalized 
to the shNT control group. The effect of sh#2 was most dramatic, with an 88% decrease in 
control conditions, a 94% decrease at 48 hours starvation, and an 84% decrease at 72 hours 
starvation. By contrast, sh#8 was not as efficient but still showed a significant level of 
knockdown: at control conditions, cells had a 55% lower level of PKM2 expression; at 48 
hours, it was 78% lower; and after 72 hours, it was 75% lower (Figure 5B). 
Protein levels of LC3B expression were probed across treatment groups to detect 
autophagosome formation, a hallmark of increased autophagic processes. Two bands are 
detected with aLC3B probing: the heavier band is LC3B-I (19 kDa), a cytosolic protein originally 
believed to aid in microtubule association and dissociation; the lighter band is LC3B-II (17 
kDa), a ubiquitylated form of LC3B-I that is only formed after autophagosome formation by 
E1-ligase-like Atg proteins and subsequently degraded by lysosomal proteases when 
autolysosomes form.33 Thus, the presence of LC3B-II in relation to LC3B-I is more indicative 
of autophagosome formation and autolysosomal processing. To this end, relative expression 
of these two bands were quantified. It was seen that sh#8 cells at 48 and 72 hours had a 
relative increase in LC3B-II levels, with .27 and .63 greater II:I signal ratio than the control-
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treated cells (Figure 5C). Sh#2 cells also showed a similar increase, though to a lesser extent 
than sh#8-treated cells, with a 0.1 and 0.01 increase in ratio (Figure 5C). An actin 
housekeeping gene control is shown. Loading of protein samples across the treatment groups 
was relatively the same and any differences were statistically insignificant (Figure 5D). 
Therefore, it appears that Huh7 cells that show a knockdown of PKM2 expression also 
exhibited increased levels of autophagy.  
 
Knockdown of PKM2 isoform in Hep3B cells was difficult to establish. 
 
To investigate whether this knock-down effect and increase in autophagic processes 
was a cell line-specific phenomenon, an additional colony of carcinoma cells were established 
and manipulated. Hep3B was originally isolated via biopsy from an 8-year-old Black male, and 
has been well-studied and characterized.34 This line was chosen for its wide availability, 
expression of enzymes, and its ability to tolerate a variety of culture conditions. However, the 
establishment of a stable knock-down line proved to be exceedingly difficult in my time 
working with the line. 
Initially, viral-transduction knockdown was attempted to produce a stable line. A 293T 
packaging line was established once more and viral media was applied to Hep3B cells for 3 
days. Since sh#8 seemed to produce the greatest knockdown and autophagy-inducing effects 
in the Huh7-line, it was used as the sole knockdown agent. However, WBA revealed that the 
expression of PKM2 appeared to increase upon infection with sh#8-containing lentivirus, 
despite proper loading of the gel (Figure 6). It is possible that the samples were loaded 
improperly into the gel, but this seemed unlikely given the careful monitoring that I employed 
throughout my experimentation.  A second line of 293T packaging cells was established and 
viral media was collected for application to another set of Hep3B cells. In addition, a sample 
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of packaging cells was collected for WBA, which revealed that there was little knockdown 
effect seen (Figure 6).  
A third iteration of virally-transduced Hep3B cells was attempted, this time using a 
greater concentration of shRNA in liposomes with the hopes that a greater percentage of 
lentiviral particles contain these sequences. Knockdown effects were still paradoxical in 
presentation, with cells purportedly receiving the knockdown viral treatment showing no 
difference in PKM2 expression or even heightened levels of expression. Probing for autophagy 
markers revealed a sporadic expression of LC3B-II: control condition knockout cells appear to 
have slightly elevated LC3B-II presentation compared to NT control; 48 hour starvation knock 
down cells show a similar level of heightened autophagy; however, 72 hour starvation 
knockdown cells have almost no autophagy levels when compared with NT control; the lower 
levels of autophagy also was seen in 293T cells (Figure 7).  A fourth attempt at viral-
transduction was made in conjunction with transient transfection – a process that involves 
direct transmission of shRNA plasmid into cells via lipofection. The packaged cells showed 
little to no knockdown effect, and the transiently transfected cells also exhibited minimal 
knockdown effects (Figure 8). Nevertheless, a starvation experiment was conducted to see if 
autophagy levels was different among these manipulated cells. Unfortunately, the loading of 
the gel was poor and resulted in a blot that was difficult to interpret (Figure 8). Probing for 
LC3B proved to show almost no levels of autophagy since the presence of processed LC3B-II 
was not detected. The poor transfection efficiency could be attributed to the timing and 
seeding density of the cells; because the cells had been seeded a few days prior to 
transfection, and because the dishes were 80-90% confluent, the surface area of cells was 
not as optimal as it would be at 24 hours post-seeding and the division rate of cells was also 
not as rapid (Figure 9).  
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A fifth attempt at virally-transfecting 293T cells and lentiviral transduction of Hep3B 
cells was undertaken utilizing ultracentrifugation. As detailed in the Materials & Methods 
section and briefly detailed here, viral media was collected from transfected 293T cells every 
24 hours over the course of 3 days; each time viral media was taken up by syringe and pooled 
into a sterile Falcon tube through a 0.45 nm pore filter, after which fresh DMEM media was 
added dropwise to the cells. After all media had been pooled, the entire volume was 
transferred to a sterile polypropylene tube and ultracentrifuged for 2 hours at 25,000 rpm at 
4ºC. Reconstituted virus was then applied to Hep3B cells to infect and incubate for 3 days. A 
series of puromycin selection was used to allow for transduced cells to grow out into the 
population; however, upon WBA it appeared that this method of concentrated viral infection 
still could not yield a meaningful knock down phenotype (Figure 10). A last attempt using 
optimized transient transfection techniques failed to produce a knocked down phenotype of 
PKM2 in Hep3B cells (Figure 11).  
 
Overexpression of PKM2 in Hep3B cells led to a decrease in autophagosome formation. 
 
The next logical step in understanding the role of PKM2 in autophagy was to observe 
the effects of overexpression within cells. Due to the time constrains of this project, it was 
thought that utilizing Hep3B cells for both knock down and overexpression studies would be 
most economic, even with the ongoing difficulties of manipulating gene expression in this line. 
In order to overexpress PKM2, a plasmid containing this gene under a constitutive promoter 
was isolated and transfected into cells. The construct was the pPKM2-EGFP plasmid that was 
isolated from bacterial agar stab stock. A pCMV-FLAG empty vector was used as a negative 
control. Initially, overexpression plasmid was purchased as a bacterial stock stored in an agar 
stab and stored at -20ºC. However, reconstitution and streaking of this stock did not produce 
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any viable colonies, even after three attempts (data not shown). Luckily, Dr. Jianguo Wu had 
a previously isolated concentrated sample of plasmid that was produced from an earlier 
experiment, which he kindly gifted for my experimental use. These two plasmids were 
combined with PEI at 2µg/well and transfected transiently. First pass transient transfection 
was unsuccessful and produced cells that had no differences in PKM2 expression (Figure 12). 
In addition, the use of a thinner gel and lower well volume led to improper loading that leaked 
across well boundaries, thus resulting in staggered bands with bleeding. After two more 
attempts, however, the level of PKM2 expression was greatly increased in pPKM2-EGFP 
transfected cells when compared to pCMV-FLAG treated cells (Figure 13). Control condition, 
overexpression cells had a 1.37-fold increase in PKM2 expression, 48-hour starved 
overexpressed cells showed a .39-fold increase, and 72-hour starved overexpression cells 
had a 0.25-fold increase compared to empty vector control (Figure 13B). It is also notable that 
expression of PKM2 decreased over the course of starvation in control cells, thus making the 
relative greater expression of PKM2 in treated cells all the more significant (Figure 13B).  
Probing these cells for autophagy markers led to the interesting finding that increased 
PKM2 expression also increased the formation of autophagosomes in starved media 
conditions (Figure 13D-F). The effect of induced autophagy was not as drastic as that of the 
knockdown conditions seen previously; however, control condition overexpression cells 
exhibited a 0.06 decrease in ratio, 48-hour starved overexpression cells show a 0.19 
decrease, and 72-hour starved overexpression cells show a 0.42 increase in ratio (Figure 13D-
F). Unfortunately, time constraints did not allow for the probing of actin controls to normalize, 
but these findings show some preliminary evidence that overexpressed cells have a more 
complex mechanism of autophagy induction when metabolically challenged than previously 
thought. Thus, overexpression of PKM2 in Hep3B cells led to a mild decrease in autophagy of 
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control and minimally starved cells, but a large increase in starved cells that were challenged 
for a longer period of time.  
 
Discussion 
 
In this study, I show that modulating the level of pyruvate kinase isoform M2 led to a 
change in the levels of autophagy. More specifically, the knockdown of PKM2 in Huh7 led to 
an increase in autophagosome formation and autolysosome function, which are functionally 
indicative of autophagy and related processes. As demonstrated by the several western blots, 
the knockdown efficiency of Huh7 cells was between 50-94%, with sh#2 treatment being the 
more efficient of the two shRNA constructs used. The levels of autophagy do not seem to 
exhibit a linear relationship with levels of knockdown, however. At the lower efficiency sh#8 
knockdown (i.e. “mild” knockdown) levels, the levels of autophagy were .41-fold and .70-fold 
greater at 48- and 72-hours starvation, respectively (Figure 5D). Assuming cancer cells have 
a greatly increased drive to divide and proliferate, it might be a possibility that the “mild” KD 
effect is downregulating the dimeric, biosynthetic activity of the PKM2 dimer form found in 
most cancers.35 In this way, the previously productive rate of biosynthesis would slow, and 
dividing cells would require the replenishment through alternative means in starved 
conditions, namely autophagy. Higher efficiency knockdown has the effect of severely 
dampening biosynthesis in hepatocytes, and thus the rate of division either decreases or cell 
death occurs through a variety of means. Indeed, upon examination of the cell culture dish, 
the morphology of cells in the sh#2 treatments was smaller in size than other cells as well as 
less confluent upon collection (data not shown). To this end, a working model of knocked 
down PKM2 cells is shown in Figure 15. 
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Knockdown of PKM2 in Hep3B cells was difficult to produce, and the effect on autophagy as 
seen in Huh7 cells could not be replicated.  
Two approaches were conducted to try and establish a stable line: (1) viral transduction and 
(2) transient transfection. The first attempt at packaging and infection was done with 1.5µg 
of DNA and the two envelope and packaging viral components. Several errors were made that 
probably contributed to the low infectivity and transduction, including but not limited to not 
aspirating old media off of target cells after viral application (leading to dilution of newly 
introduced virus), adding puromycin selection agent too early before colonies of transfected 
cells could grow, and/or poor handling of 293T packaging cells that lifted off the bottom of 
the cell culture plate. A second round was conducted, ensuring that all media was added 
dropwise to 293T cells in a manner that did not disturb them, and carefully aspirating off old 
media when applying new viral media. A possible reason why this did not yield high efficiency 
was due to the confluency of Hep3B cells upon starting transduction (Figure 14). A third 
iteration was then carried out, but was established a week prior to spring break, wherein the 
prepared cells were not collected and died due to a miscommunication between my post-doc 
mentor and myself. A final fourth and fifth attempt was made to virally transduce the cells 
with no success, possibly due to the high passage number of the target cells. 
 The second method of transient transfection followed standard protocol. The first time 
it was carried out, the Hep3B cells were likely too confluent and led to poor uptake. On second 
trial, the master mix of transfection solution was not properly made, since PEI was added in 
3x too high of concentration; since it is toxic to cells, this led to a high percentage of cell death 
rather than higher efficiency as I had wishfully surmised. The third repetition of this technique 
yielded surprisingly low concentrations of protein, especially for the knockdown and starved 
cells despite collecting almost equal volumes of cells from culture. This imbalanced loading 
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into the gel contributed to the apparent knockdown phenotype observed in Figure 11. Due to 
these complications, a stable line was not able to be established in the time I worked in the 
lab and must be optimized further to validate our initial findings seen in Huh7 cells. 
 
Overexpression of PKM2 in Hep3B cells led to metabolically-dependent induction of 
autophagy.  
Due to the low success of viral transduction and establishment of stable lines for knockdown, 
transient transfection was chosen as the sole method for observing overexpression effects. 
Three attempts were made to transiently transfect a pPKM2-EGFP plasmid under a CMV 
promoter, which was successfully observed as seen in Figure 13. Overexpression levels were 
observed at 2.37-fold, 2.27-fold, and 2.05-fold greater levels than their respective control 
treated cells (Figure 13). Overexpression efficiency was observed at a higher rate in part 
because this level includes non-transfected cells that are expressing PKM2 concurrently, and 
in part because producing more product biologically requires fewer steps than the inhibition 
by silencing complexes like RISC. Probing these cells for LC3B showed that complete media 
conditions led to a 0.10-fold decrease in LC3B-II appearance, 48-hour starvation led to a 0.22-
fold decrease in appearance, but 72-hour starvation correlated with a 0.49-fold increase in 
appearance for overexpression cells (Figure 13). The levels of autophagy here are surprising, 
but not unexpected according to the paradigm initially hypothesized from the knock down 
data. According to the model, higher overexpression of PKM2 would lead to greater basal 
levels of biosynthesis; therefore, only during severely starved conditions will the cancer cell 
turn towards autophagy (Figure 15). Extrapolating this further, it might be that mild levels of 
overexpression (i.e. a more active form of the canonical tumor cell that highly expresses this 
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isoform) leads to lower levels of autophagy across all starvation conditions. These findings 
must be validated further using additional cell culture studies. 
 
Resource Depletion-Induced Autophagy Model 
From these preliminary findings and extrapolation, a working model for induction of autophagy 
in knockdown and overexpressing PKM2 cells was hypothesized. According to this model, 
resources for cell hyperproliferation are required for the cancerous tissue. A cell that requires 
greater biosynthetic intermediates requires either a heightened rate of anabolism, or a rapid 
rate of component recycling. At low expression levels of PKM2, the dimeric and non-
glycolytically active form does not push the cell towards biosynthesis pathways an effectively. 
As such, the cell must increase its autophagic processes to compensate for this drop in 
resources, which exacerbates as the cell undergoes starvation conditions. For a certain 
amount of time, the cell is able to replenish its depleted intermediates until, at a critical point 
(the start of the “therapeutic window”), the cell loses its ability to survive the degradative 
turnover of its components and leads to greater instances of cell death (Figure 15A). It is 
thought, therefore, that inducing greater autophagy in these knocked down cells could induce 
higher levels of turnover that lead to cell susceptibility to death. 
By contrast, the model also accounts for the overexpression of PKM2 in HCC cells and 
the observation that autophagy also increases, though at later stages of starvation. Because 
higher levels of dimeric PKM2 are present in the cells, there does not need to be as high levels 
of autophagy in normal, or even in early stages of starvation. However, past a critical point 
(“therapeutic window”), the cell must turn to autophagy to restore its depleted resources for 
cell proliferation. The rate of autophagy was observed to be much higher at these later stages 
of starvation, and therefore the recycling pathway must be working at increased levels to 
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compensate for the sudden withdrawal from anabolic processes catalyzed by increased PKM2 
levels (Figure 15B). As such, it would be therapeutically targetable to inhibit autophagy in 
these cells under such high metabolically stressed conditions in order to push the cell farther 
towards apoptotic pathways. Due to the interplay between apoptosis and autophagy and the 
general trend that tumor cells preferentially express PKM2, this method of autophagic 
inhibition is hypothesized to work particularly well as a therapeutic treatment.16 In both 
instances, it would be interesting to observe the potential synergistic effects of other 
pharmacologic agents that take advantage of the altered metabolism of cancer cells.  
Though the amount of reportable data and findings from this University Scholar project 
was minimal, a great deal about molecular biology, physiology, and liver cancer techniques 
and experimental approaches was imparted to me. Perhaps the greatest takeaway is the hard 
work needed to conduct cell culture studies, the fact that cells often do not behave in ways 
that are predictable owing to the complexity with which they grow, divide, and proliferate, and 
the difficulty in successfully manipulating gene expression within cells. Transfection efficiency 
proved to the limiting factor across all the experiments conducted in this study. Even with 
optimizing concentrations, times of transfection, media, and lipofection agents, efficiencies 
rarely approached that of other published studies – a benchmark of industry 
standards/standards of the field. To this end, the follow-up studies I had planned on 
conducting to more fully understand the complex interaction between PKM2 and autophagy 
could not be completed in the few semesters I had to work in the lab. On top of coursework 
and other things, balancing time to schedule experiments and troubleshoot was a significant 
logistical challenge. Nevertheless, this experience points to the need for dedicated research 
periods, which I look forward to pursuing in my graduate studies. Overall, my experience with 
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this project yielded a few interesting findings and affirmed my passion to continue biomedical 
research in pursuit of basic science and translational knowledge.  
 
A few future directions are necessary to flesh out the larger picture of PKM2’s role in 
autophagy in HCC cells.  
First, a secondary line of HCC cells must be established to recapitulate the findings of 
the Huh7 knockdown cells. This is to ensure that it is a HCC-specific observation that is 
validated across multiple cell types, rather than a severely limited sample set. Hep3B cells 
have been shown to be able for transfection, and the overexpression data demonstrate that 
it is possible. To optimize this protocol further, I might also purchase or synthesize addition 
shRNA constructs that have higher target ability and use a greater concentration and larger 
cell population. I would expect to see a similar level of knockdown efficiency in the cell line 
followed by a concomitant increase in autophagy levels for knockdown and starved cells.  
Concurrently, I would repeat the overexpression study in the Huh7 cell line to observe 
autophagy levels. In addition, I might try to modulate the overexpression levels of PKM2 
through chemical means (CHX translation inhibition) in order to further support the working 
model hypothesized. I would expect to see an effect of increased autophagy only in greatly 
starved/stressed cells. In other words, I would expect to see lower levels of autophagy 
compared to basal level controls in conditions that are optimal for tumor growth, and these 
levels would increase in a direct relationship to the level of PKM2 expression (decreasing 
levels of CHX treatment.) 
In addition to working with flat, one-dimensional cell culture, I would attempt to use 
tumor spheroids in vitro because they have been shown to be more realistic in simulating in-
vivo tumors.36 The establishment of knockdown and overexpressed cells would require the 
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use of the rotary cell culture system.37 In this system, cells are grown in standard cell culture 
and then isolated as single cells and grown in a rotating flask so that they do not adhere to 
the sides. WBA and other techniques could be used in the same fashion to probe for changes 
in autophagy as in monolayer flasks, though more complex imaging and diagnostic tests could 
be used to observe overall phenotype and morphology as well as metastasis.  
Once these findings have been observed, I would move on to establish ties to clinical 
significance. The following are the experiments I would carry out to investigate whether the 
modulation of autophagy levels synergizes current cancer therapies, or if it can alter the 
metabolic function of cancer cells to meaningfully reduce their oncogenic characteristics and 
decrease tumor progression.  
I would attempt to exploit the therapeutic windows of autophagy and cell survival 
established by my model. By targeting the knockdown cells at the higher end of autophagy, in 
essence inducing greater levels of autophagy, I predict a decrease in cell viability due to 
autophagy-associated death. To accomplish this, I would apply autophagy inducers in addition 
to knockdown constructs, and observe cell viability using an MTS assay, PARP cleavage, or 
flow cytometry (AnnexinV/PI). I would expect to see a greater level of cell death in cells that 
have been knocked down and autophagy-induced. Furthermore, I would observe whether 
these effects synergize with those of other HCC drugs currently on the market or in Phase II 
clinical trial in an attempt to improve their efficacy. 
Conversely, I would attempt to target the mutually-inhibitory relationship between 
autophagy and apoptosis for overexpressed cells.16 According to the RDAM model, I would 
target the low autophagy levels at normal media conditions and inhibit autophagy further, 
using the chemical inducer 3-MA and measure cell viability. These effects should be magnified 
upon metabolic starvation since the cells should attempt to rescue their proliferative ability 
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through autophagy but will instead undergo an apoptotic pathway. I would expect to see lower 
cell viability throughout all conditions, with a steep drop in viability at highly metabolically 
stressed cells. This effect could also be synergizing with other therapeutics and should be 
explored to find an appropriate pairing that could be clinically applicable.  
 I would then move to in-vivo mouse models to validate these findings in a living model 
system, with the hopes of establishing phenotypic and functional pre-clinical significance. By 
using patient-derived xenografts in SCID/NOD mice, I would measure tumor size and observe 
histology of treatment with autophagy inhibitors, and knockdown constructs + inducers + 
therapeutics. I would expect to see a decrease in tumor size for fasting mice upon treatments, 
with greater levels of cell death upon autophagy induction for knockdown-treated cells and 
upon apoptosis induction for overexpressed cells. A Kaplan-Meier curve could be constructed 
for a group of mice to be monitored over a longer time course to see if treatment is a viable 
mode of clearing a tumor and allowing for increased survival.  
 
Final Remarks 
Overall, this study provides an interesting claim that PKM2 modulates the activity of 
autophagic properties to aid in the proliferation and growth of HCC cells. By changing 
expression levels within cells, it is possible to induce a resource-depletion-induced flurry of 
autophagy activity and establish a therapeutic window to either increase or decrease 
autophagy and lead to cell susceptibility to death. In total, this project demonstrates that HCC 
cells have autophagy processes that are influenced by PKM2 expression, and that this 
pathway requires greater investigation for potential further clinical application. 
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Figure 3. Knockdown levels of PKM2 in first-pass 293T viral-packaging cells is not efficient. 
Relative expression of protein was analyzed via ImageJ software and signal was calculated as 
area under the curve (AUC). Expression levels were normalized to non-targeting control levels. 
Top arrow indicates the bands at ~58 kDa, the predicted monomeric form of PKM2; bottom 
arrow indicates either a non-specific binding of antibody, or Hsp40, a binding partner of PKM2 
in its glycolytically inactive state.38  
 
        
 
Figure 4. Huh7 cells transduced with sh#2 and sh#8 lentivirus exhibited knockdown 
expression of PKM2. Samples were loaded in reverse order, by accident, but a noticeable 
decrease in expression was observed in the knock-down treated cells.  
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Figure 5. Huh7 cells virally-transduced appear to have knockdown phenotypes. (A) Efficient 
knockdown of PKM2 in Huh7-transduced cells. (B) Quantification of knocked down expression 
in Huh7 cells. (C) Knockdown cells show an increase in LC3B-II expression (lighter band) in 
comparison to LC3B-I expression (heavier band). (D) Actin control shows equal loading 
concentrations. 
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Figure 6. Initial lentiviral knockdown exhibited paradoxical PKM2 expression. On left, PKM2 
expression appears to be greater in shRNA-treated cells than in non-targeting control cells. On 
right, actin controls are shown for both samples. 
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Figure 7. Inefficient transfection and transduction yields unpatterned expression of PKM2 and 
LC3B-II. (A) 293T transfected cells do not show PKM2 knocked down expression. (B) Non-
efficiently virally-transduced Hep3B cells have differential PKM2 expression, virally-
transfected 293T packaging cells show no knock down effect. (C) Hep3B cells show variable, 
but low levels of autophagy.  
  
 
 
 
 
Figure 8. Fourth attempt at viral transfection knockdown and transiently transfection of 
Hep3B cells. (A) Transiently transfected Hep3B cells cannot be meaningfully interpreted due 
to loading errors. (B) Almost no levels of autophagy were detected.  
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Figure 9. Schematic of several cell culture techniques. (A) Lentiviral packaging and infection 
followed by western blot analysis. (B) Optimal seeding of target cells prior to transfection.   
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Figure 10. Ultracentrifuged concentrated lentivirus yields no efficient transduction of Hep3B 
cells.  
 
 
 
 
Figure 11. Transiently transfected knockdown in Hep3B cells. The drop in PKM2 expression 
of sh#8-treated cells at 48 and 72 hours was due to low concentrations and therefore 
decreased amount of protein available to load into the well.    
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Figure 12. Initial overexpression transfection showed no signs of upregulated expression of 
PKM2.  
 
 
Figure 13. Third round overexpression transfection successfully established increased 
expression of PKM2 in Hep3B cells. (A) PKM2 overexpression. (B) Table of quantified 
expression levels. (C) Graphical representation of quantified data as in (B). (D) LC3B-probed 
WBA. (E) Quantification of LC3B-II ratio to LC3B-I. (F) Graphical representation of quantified 
data as in (E). 
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Figure 15. The Resource Depletion-Induced Autophagy Model (Depletion Autophagy Model). 
(A) Wild-type (WT), knockdown (KD) and overexpression (OE) cell autophagy levels and cell 
viability are plotted as functions of starvation time. WT relative autophagy increases as 
starvation time increases, and cell viability decreases concurrently. KD and OE autophagy 
levels increase at a greater rate after 60 hours and cell viability decreases at a slower rate. 
(B) All curves are shown in this plot. The boxed area indicates the “therapeutic window,” or 
the area at which targeting autophagy leads to heightened effects on cell viability. (C) A 
schematic showing the DAM in HCC cells. 
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Figure 16. MTS assay transformed to cell viability for wild-type, knockdown, overexpression, 
and overexpression plus autophagy inhibitor 3-methyladenine (3-MA).  
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